Study to Investigate Efficacy and Safety Equivalence of OsvaRen Tablets and OsvaRen Granules

Trial Profile

Study to Investigate Efficacy and Safety Equivalence of OsvaRen Tablets and OsvaRen Granules

Completed
Phase of Trial: Phase II/III

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Calcium acetate/magnesium carbonate (Primary) ; Phosphate binding modulators
  • Indications Kidney disorders
  • Focus Therapeutic Use
  • Acronyms OsvaRen NEW
  • Sponsors Fresenius Medical Care
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Apr 2015 Planned End Date changed from 1 May 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top